Zobrazeno 1 - 10
of 289
pro vyhledávání: '"And J. Schlom"'
Autor:
J.L. Gulley, A. Bayliffe, R. Donahue, Y.T. Tsai, K. Liu, M. Katraggada, J. Hsu, L.L. Siu, E.J. Wherry, R. Chopra, J. Schlom, Z. Su
Publikováno v:
European Journal of Cancer. 174:S5
Autor:
R.A. Madan, R. Donahue, Y-T. Tsai, F. Karzai, S. Gandhy, M. Bilusic, P. Arlen, M. Theoret, J. Marte, L. Cordes, A. Couvillon, A. Hankin, M. Williams, S. McMahon, W.D. Figg, W. Dahut, J. Schlom, J. Gulley
Publikováno v:
Annals of Oncology. 33:S1191
Autor:
J. Redman, A. Spira, M. Javle, K. Kelly, N. Pavlakis, G. Jehl, M. Gatti-Mays, L. Cordes, C. Alewine, C. Pico-Navarro, J. Zebala, R. Ito, J. Marte, J. Strauss, C. Floudas, D. Pastor, D. Francis, E. Redmond, J. Gulley, J. Schlom
Publikováno v:
Annals of Oncology. 33:S297
Autor:
James L. Gulley, Elizabeth Lamping, Jason M. Redman, J. Schlom, Lisa M. Cordes, Laureen S. Ojalvo, Byoung Chul Cho, Edward F. McClay, Julius Strauss, Houssein Abdul Sater, Fatima Karzai, Marijo Bilusic, Sébastien Salas, Margaret E. Gatti-Mays, Ravi A. Madan, A. Hill, Jennifer L. Marte, G. Jehl
Publikováno v:
Annals of Oncology. 32:S829
Publikováno v:
Cancer Research. 78:P3-05
It has been reported that the Natural killer (NK) cell with FCGR3A (CD16a) V genotype is associated with enhanced clinical response to IgG1 monoclonal Ab (mAb) therapy such as trastuzumab, rituximab and cetuximab (1,2), suggesting a role of antibody-
Autor:
Charalampos S. Floudas, Jung-Min Lee, Anish Thomas, Julius Strauss, Lisa M. Cordes, Fatima Karzai, G. O'Sullivan Coyne, Jason M. Redman, Jennifer L. Marte, Margaret E. Gatti-Mays, Ravi A. Madan, Andrea B. Apolo, H. Abdul Sater, James L. Gulley, Alice P. Chen, Marijo Bilusic, Arun Rajan, J. Schlom
Publikováno v:
European Journal of Cancer. 138:S10
Autor:
Myrna Rauckhorst, Renee N. Donahue, Lisa M. Cordes, Marijo Bilusic, Fatima Karzai, N. Williams, J. Schlom, William L. Dahut, Anna Couvillon, Susan Wroblewski, Xiao X. Wei, Amy Hankin, Philip W. Kantoff, James L. Gulley, Philip M. Arlen, Nicole Toney, Ravi A. Madan, Susan F. Slovin, Julius Strauss, Lauren C. Harshman
Publikováno v:
Annals of Oncology. 31:S542
Autor:
Jason M. Redman, Julius Strauss, Jennifer L. Marte, J. Schlom, H. Abdul-Sater, Marijo Bilusic, N. Williams, Michell Manu, Fatima Karzai, Amy Hankin, Charalampos S. Floudas, Ravi A. Madan, James L. Gulley, Lisa M. Cordes, William L. Dahut, Seth M. Steinberg, Margaret E. Gatti-Mays
Publikováno v:
Annals of Oncology. 31:S511
Autor:
H. Abdul Sater, Jason M. Redman, Ravi A. Madan, Benjamin A. Weinberg, J. Schlom, J.-M. Lee, Fatima Karzai, Margaret E. Gatti-Mays, Lisa M. Cordes, Shahrooz Rabizadeh, Seth M. Steinberg, Patrick Soon-Shiong, Jennifer L. Marte, Renee N. Donahue, S. Gandhy, Yo-Ting Tsai, John L. Marshall, Julius Strauss, Sheri McMahon, Sunnie S. Kim, Marijo Bilusic, James L. Gulley
Publikováno v:
Annals of Oncology. 31:S227
Autor:
M. Tuschen, James L. Gulley, Jennifer L. Marte, S. Bhandari, P Budde, J. Schlom, P Schulz-Knappe, Ravi A. Madan, H.-D. Zucht
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Autoantibodies (AAB) targeting self-antigens can be found in two clinically and immunologically opposing diseases, autoimmune diseases and cancer. While in autoimmune diseases, the immune system is hyperactivated against self-antigens, man